Literature DB >> 16781782

MBP-PLP fusion protein-induced EAE in C57BL/6 mice.

Stefanie Kuerten1, Felix S Lichtenegger, Susan Faas, Doychin N Angelov, Magdalena Tary-Lehmann, Paul V Lehmann.   

Abstract

Gene knock-out and knock-in mice are becoming increasingly indispensable for mechanism-oriented studies of EAE. Most gene-modified mice are on the C57BL/6 background, for which presently there are only two EAE models available, the MOG peptide 35-55 and the PLP 178-191 peptide induced disease. However, because MS is not a single pathogenic entity, different EAE models are required to reproduce and study its various features. Here we are introducing MBP-PLP fusion protein (MP4)-induced EAE for C57BL/6 mice. B cell- and CD8+ T cell-dependence, as well as multi-determinant recognition are among the unique features of this demyelinating EAE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781782     DOI: 10.1016/j.jneuroim.2006.03.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  17 in total

1.  MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

Authors:  Stefanie Kuerten; Dilyana A Kostova-Bales; Lukas P Frenzel; Justine T Tigno; Magdalena Tary-Lehmann; Doychin N Angelov; Paul V Lehmann
Journal:  J Neuroimmunol       Date:  2007-07-25       Impact factor: 3.478

Review 2.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

3.  Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.

Authors:  Tobias M Nowacki; Stefanie Kuerten; Wenji Zhang; Carey L Shive; Christian R Kreher; Bernhard O Boehm; Paul V Lehmann; Magdalena Tary-Lehmann
Journal:  Cell Immunol       Date:  2007-09-07       Impact factor: 4.868

4.  Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis.

Authors:  Stefanie Kuerten; Sita Javeri; Magdalena Tary-Lehmann; Paul V Lehmann; Doychin N Angelov
Journal:  Clin Immunol       Date:  2008-08-23       Impact factor: 3.969

5.  MANF Is Neuroprotective in Early Stages of EAE, and Elevated in Spinal White Matter by Treatment With Dexamethasone.

Authors:  Jinhan Nam; Tapani K Koppinen; Merja H Voutilainen
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

Review 6.  Gastrointestinal motility disorders in patients with multiple sclerosis: A single-center study.

Authors:  Lehar Khanna; Burcu Zeydan; Orhun H Kantarci; Michael Camilleri
Journal:  Neurogastroenterol Motil       Date:  2022-02-03       Impact factor: 3.960

Review 7.  Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.

Authors:  Andrea Rottlaender; Stefanie Kuerten
Journal:  Int J Mol Sci       Date:  2015-07-01       Impact factor: 5.923

8.  Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.

Authors:  Johanna Prinz; Aylin Karacivi; Eva R Stormanns; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

9.  CEACAM1 mediates B cell aggregation in central nervous system autoimmunity.

Authors:  Damiano M Rovituso; Laura Scheffler; Marie Wunsch; Christoph Kleinschnitz; Sebastian Dörck; Jochen Ulzheimer; Antonios Bayas; Lawrence Steinman; Süleyman Ergün; Stefanie Kuerten
Journal:  Sci Rep       Date:  2016-07-20       Impact factor: 4.379

10.  Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.

Authors:  Andreas Arndt; Peter Hoffacker; Konstantin Zellmer; Oktay Goecer; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.